Yaşlı Hastalarda Yanık Yönetimi
Özet
Yaşlı nüfusun artmasıyla birlikte yanık vakaları ve buna bağlı mortalite oranları, fiziksel zayıflık, cilt kalınlığının azalması ve komorbid hastalıklar nedeniyle yükselmektedir. Yaşlılarda yanık sonrası metabolik, inflamatuvar süreçler ve kök hücre yetersizliğine bağlı yara iyileşmesi gençlerden farklı olup, 14 günden sonra artan hipermetabolik ve hiperinflamatuvar yanıt ile insülin direnci gözlenmektedir. En yüksek mortalite nedeni inhalasyon yanıklarıyken, cerrahi gereksinim duyan hastalarda ölüm riski daha yüksektir. Bu hassas sürecin yönetimi, sepsis riskini azaltmak ve sağkalımı artırmak adına uzman ekiplerce uzun dönemli rehabilitasyon ve özel bakımevi takibi gerektirmektedir.
As the elderly population grows, burn cases and associated mortality rates rise due to physical frailty, decreased skin thickness, and comorbid diseases. Metabolic and inflammatory processes, as well as delayed wound healing due to stem cell insufficiency after burns in the elderly differ from youth, exhibiting an increased hypermetabolic and hyperinflammatory response after 14 days along with insulin resistance. While inhalation burns are the leading cause of mortality, the risk of death is higher in patients requiring surgery. Managing this delicate process requires long-term rehabilitation and specialized nursing home follow-up by expert teams to reduce the risk of sepsis and increase survival rates.
Referanslar
World Health Organisation. Burns. 2018 http://www.who.int/ news-room/fact-sheets/detail/burns. [Accessed 5 September 2018].
Kraft, R., Herndon, D.N., Al-Mousawi, A.M., Williams, F.N., Finnerty, C.C., Jeschke, M.G., 2012. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet 379, 1013–1021.
Bortolani A, Barisoni D. Burns in the elderly. Epidemiology and mortality: analysis of 53 cases. Ann Burns Fire Disasters 1997;10:197–9.
Lumenta DB, Hautier A, Desouches C, Gouvernet J, Giorgi R, Manelli JC, et al. Mortality and morbidity among elderly people with burns—evaluation of data on admission. Burns 2008;34:965–74.
Ward J, Phillips G, Radotra I, Smailes S, Dziewulski P, Zhang J, et al. Frailty: an independent predictor of burns mortality following in-patient admission. Burns 2018;44:1895–902, doi: http://dx.doi.org/10.1016/j.burns.2018.09.022.
Jeschke MG, Pinto R, Costford SR, Amini-Nik S. Threshold age and burn size associated with poor outcomes in the elderly after burn injury. Burns 2016;42:276–81.
Pham TN, Kramer CB, Wang J, Rivara FP, Heimbach DM, Gibran NS, et al. Epidemiology and outcomes of older adults with burn injury: an analysis of the National Burn Repository. J Burn Care Res 2009;30:30–6.
Ho WS, Ying SY, Chan HH. A study of burn injuries in the elderly in a regional burn centre. Burns 2001;27:382–5.
Moore EC, Pilcher DV, Bailey MJ, Cleland H, McNamee J. A simple tool for mortality prediction in burns patients: APACHE III score and FTSA. Burns 2010;36:1086–91.
Duvall DB, Zhu X, Elliott AC, Wolf SE, Rhodes RL, Paulk ME, et al. Injury severity and comorbidities alone do not predict futility of care after geriatric trauma. J Palliat Med 2015;18:246–50.
Gerstein, A.D., Phillips, T.J., Rogers, G.S., Gilchrest, B.A., 1993. Wound healing and aging. Dermatol. Clin. 11, 749–757.
Solanki NS, Greenwood JE, Mackie IP, Kavanagh S, Penhall R. Social issues prolong elderly burn patient hospitalization. J Burn Care Res 2011;32:387–91.
Grimble, R.F., 2003. Inflammatory response in the elderly. Curr. Opin. Clin. Nutr. Metab. are 6, 21–29.
Jeschke MG, Patsouris D, Stanojcic M, Abdullahi A, Rehou S, Pinto R, et al. Pathophysiologic response to burns in the elderly. EBioMedicine 2015;2:1536–48.
Cazalis, M.A., Friggeri, A., Cave, L., et al., 2013. Decreased HLA-DR antigen-associated in- variant chain (CD74) mRNA expression predicts mortality after septic shock. Crit. Care (Lond. Engl.) 17, R287.
Demaret, J., Walencik, A., Jacob, M.C., et al., 2013. Inter-laboratory assessment of flow cyto- metric monocyte HLA-DR expression in clinical samples. Cytometry B Clin. Cytom. 84, 59–62
Shumakov, V.I., Onishchenko, N.A., Rasulov, M.F., Krasheninnikov, M.E., Zaidenov, V.A., 2003. Mesenchymal bone marrow stem cells more effectively stimulate regeneration of deep burn wounds than embryonic fibroblasts. Bull. Exp. Biol. Med. 136, 192–195.
Teta, M., Long, S.Y., Wartschow, L.M., Rankin, M.M., Kushner, J.A., 2005. Very slow turn- over of beta-cells in aged adult mice. Diabetes 54, 2557–2567.
Kuang, W., Xu, X., Lin, J., et al., 2015. Functional and molecular changes of MSCs in aging. Curr. Stem Cell Res. Ther. (Epub Ahead of print).
Harats M, Peleg K, Givon A, Kornhaber R, Goder M, Jaeger M, et al. Burns in Israel, comparative study: demographic, etiologic and clinical trends 1997–2003 vs. 2004–2010. Burns 2016;42:500–7.
Ofir H, Shefler H, Kornhaber R, Cleary M, Harats M, Haik J. Purpose-built national burns center: the Israeli experience. Nurs Health Sci 2018;20:255–63.
Haik J, Liran A, Tessone A, Givon A, Orenstein A, Peleg K. Burns in Israel: demographic, etiologic and clinical trends, 1997- 2003. Isr Med Assoc J 2007;9:659–62.
Khadim MF, Rashid A, Fogarty B, Khan K. Mortality estimates in the elderly burn patients: the Northern Ireland experience. Burns 2009;35:107–13.
